Effects of MCI-154, a new cardiotonic Ca2+ sensitizer, on ventricular arrhythmias and membrane ionic currents

European Journal of Pharmacology

Volumn 298, Issue 3, 1996, Pages 247-256

  Eto, Koji ^a   Xue, Yi Xue ^a   Hashimoto, Keitaro ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Ca2+; Current; Heart failure; MCI 154 (6 4 (4 pyridylamino)phenyl 4,5 dihydro 3 (2H) pyridazinone); Ventricular arrhythmia

Indexed keywords

4,5 DIHYDRO 6 [4 (4 PYRIDYLAMINO)PHENYL] 3(2H) PYRIDAZINONE; ADRENALIN; CALCIUM SENSITIZER; CARDIOTONIC AGENT; DIGITALIS; INOTROPIC AGENT; OUABAIN; PIMOBENDAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARRHYTHMOGENESIS; ARTICLE; BOLUS INJECTION; CALCIUM CURRENT; CONCENTRATION RESPONSE; CONTINUOUS INFUSION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DOG; DRUG BLOOD LEVEL; FEMALE; GUINEA PIG; HEART MUSCLE CELL; HEART VENTRICLE ARRHYTHMIA; INTRAVENOUS DRUG ADMINISTRATION; ION CURRENT; MALE; MEMBRANE CURRENT; NONHUMAN; PRIORITY JOURNAL; VOLTAGE CLAMP;

ANIMALS; ARRHYTHMIA; CALCIUM; CARDIOTONIC AGENTS; CELL MEMBRANE; CORONARY VESSELS; DOGS; ELECTROPHYSIOLOGY; EPINEPHRINE; FEMALE; GUINEA PIGS; HEART VENTRICLES; ION CHANNELS; MALE; MYOCARDIUM; OUABAIN; PATCH-CLAMP TECHNIQUES; PYRIDAZINES;

EID: 0029993348     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(95)00776-8     Document Type: Article

References (44)

1. Abe, Y., Y. Kitada, A. Narimatsu and A. Tobe, 1991, Improvement of postischemic contractile dysfunction of dog heart by MCI-154, a novel cardiotonic agent, Eur. J. Pharmacol. 192, 279.
2. Abe, Y., Y. Kitada and A. Narimatsu, 1992, Beneficial effects of MCI-154, a cardiotonic agent, on ischemic contractile failure and myocardial acidosis of dog hearts: comparison with dobutamine, milrinone and pimobendan, J. Pharmacol. Exp. Ther. 261, 1087.
3. Abe, Y., Y. Kitada and A. Narimatsu, 1993, Effect of MCI-154, a cardiotonic agent, on regional contractile function and myocardial oxygen consumption in the presence and absence of coronary artery stenosis in dogs, J. Pharmacol. Exp. Ther. 265, 819.
4. Abe, Y., R. Ishisu, K. Onishi, K. Sekioka, A. Narimatsu and T. Nakano, 1996, Calcium sensitization in perfused beating guinea pig heart by a positive inotropic agent MCI-154, J. Pharmacol. Exp. Ther. (in press).
5. Allert, J.A. and H.R. Adams, 1990, Inotropic and chonotropic profile of MCI-154: comparisoprenalinen with isoprenalineprenaline and imazodan in guinea pig cardiac preparations, J. Cardiovasc. Pharmacol. 16, 59.
6. Bethke, T., W. Meyer, H. Schmitz, H. Scholz, H. Wenzlaff, B.I. Armah, R. Bruckner and A. Raap, 1993, High selectivity for inhibition of phosphodiesterase III and positive inotropic effects of MCI-154 in guinea pig myocardium, J. Cardiovasc. Pharmacol. 21, 847.
7. Brunkhorst, D., H. Van der Leyen, W. Meyer, R. Nigbur, C. Schmidt-Schumacher and H. Scholz, 1989, Relation of positive inotropic and chonotropic effects ofpimobendan, UD-CG 212 Cl, milrinone and other phosphodiesterase inhibitors to phosphodiesterase III inhibition in guinea pig hearts, Naunyn-Schmied. Arch. Pharmacol. 339, 575.
8. Endoh, M., Y. Kawabata, Y. Katano and I. Norota, 1994, Effects of a novel cardiotonic agent (±)-6-[3-(3,4-dimethoxybenzylamono)-2-hydroxypropoxy]-2(1H)-quinolinone (OPC-18790) on contractile force, cyclic AMP level, and aequorin light transients in dog ventricular myocardium, J. Cardiovasc. Pharmacol. 23, 723.
9. 131I-labelled human growth hormone of high specific radioactivity, Biochem. J. 89, 114.
10. Hamil, O.P., A. Marty, E. Neher, B. Sakkmann and F.J. Sigworth, 1981, Improved patch-clamp tequniques for high-resolution current recording from cells and cell-free membrane patches, Pflüg. Arch. 391, 85.
11. Hashimoto, K. and H. Mitsuhashi, 1986, Effects of OPC-8212, a new positive inotropic agent, on canine ventricular arrhythmias, Br. J. Pharmacol. 88, 915.
12. Hashimoto, K., H. Satoh, T. Shibata and S. Imai, 1982, Canine-effective plasma concentrations of antiarrhythmic drugs on the two stage coronary ligation arrhythmia, J. Pharmacol. Exp. Ther. 223, 801.
13. Hashimoto, K., M. Ishii, S. Komori and H. Mitsuhashi, 1985, Canine digitalis arrhythmia as a model for detecting Na-channel blocking antiarrhythmic drugs: comparative study using other canine arrhythmic models and the new antiarrhythmic drugs, profafenone, tocainide anf SUN-1165, Heart Vessels 1, 29.
14. Hashimoto, K., A. Haruno and A. Hirasawa, 1990, Effects of milrinone on canine experimental arrhythmias, Coronary 7, 445.
15. Hashimoto, K., A. Haruno, T. Matsuzaki, A. Sugiyama and K. Akiyama, 1991, Effects of antiarrhythmic drugs against sustained halothane-adrenaline arrhythmia models: which electrophysiological characteristics of drugs are related to their effectiveness?, Cardiovasc. Drugs Ther. 5, 805.
16. max) in isolated contractile structures from mammalian heart muscle, Arzneim.-Forsch./Drug Res. 31, 188.
17. Hirasawa, A., T. Awaji, M. Hosono, A. Haruno and K. Hashimoto, 1993, Effects of a new folskolin derivative, NKH477, on canine ventricular arrhythmia models, J. Cardiovasc. Pharmacol. 22, 847.
18. Hosokawa, T., T. Mori, T. Fujita, S. Kinoshita, K. Takemoto, T. Imaizumi, T. Noda, M. Ohkura, M. Tominaga and Y. Yabuuchi, 1992, Cardiovascular action of OPC-18790: a novel positive inotropic agent with little chonotropic action, Heart Vessels 7, 66.
19. Hosono, M. and N. Taira, 1987, Cardiac and coronary vasodilator effects of the novel cardiotonic agent, MCI-154, assessed in isoprenalinelated, blood-perfused dog heart preparations, J. Cardiovasc. Pharmacol. 10, 692.
20. Hunter, W.M. and F.C. Greenwood, 1962, Preparation of iodine-131 labelled human growth hormone of high specific activity, Nature 194, 495.
21. Iijima, T. and N. Taira, 1987, Membrane current changes responsible for the positive inotropic effect of OPC-8212, a new positive inotropic agent, in single ventricular cells of the guinea pig heart, J. Pharmacol. Exp. Ther. 240, 657.
22. Jonas, R., M. Klockow and I. Lues, 1992, Preparation of the enantiomers of the novel Ca-sensitizer EMD 53998, Bioorg. Med. Chem. Lett. 2, 589.
23. Kanai, K., Y. Momose, K. Ogino and T. Hayashi, 1994, Effects of pimobendan on contraction and calcium currents in canine single ventricular cells, Can. J. Physiol. Pharmacol. 72 (Suppl. 1), 98.
24. Katayama, S., A. Narimatsu, R. Suzuki, T. lijima and N. Taira, 1987, Changes in membrane potentials and currents of ventricular cells of the guinea pig heart by a new cardiotonic drug, MCI-154, Jpn. J. Pharmacol. 44, 481.
25. Katz, A.M., 1992, Physioligy of the Heart, 2nd edn. (Raven Press, New York).
26. Kitada, Y., A. Narimatsu, N. Matsumura and M. Endo, 1987a, Contractile proteins: possible targets for the cardiotonic action of MCI-154, a novel cardiotonic agent?, Eur. J. Pharmacol. 134, 229.
27. 2+ sensitivity of the contractile system by MCI-154, a novel cardiotonic agent, in chemically skinned fibers from the guinea pig papillaly muscles, J. Pharmacol. Exp. Ther. 243, 633.
28. Kitada, Y., A. Narimatsu, R. Suzuki, M. Endoh and N. Taira, 1987c, Dose the positive inotropic action of a novel cardiotonic agent, MCI-154, involve mechanisms other than cyclic AMP?, J. Pharmacol. Exp. Ther. 243, 639.
29. 2+ binding by MCI-154, a novel cardiotonic agent, J. Pharmacol. Exp. Ther. 250, 272.
30. 2+ in skinned cardiac muscle, Jpn. J. Pharmacol. 50, 411.
31. Kitada, Y., Y. Abe and A. Narimatsu, 1991, Positive inotropic agents that augment Ca sensitivity and inhibit phosphodiesterase III, Jpn. J. Pharmacol. 55 (Suppl.), 44.
32. 2+-regulated interactions between troponin subunits from bovine heart, J. Pharmacol. Exp. Ther. 270, 831.
33. Lynch, J.J., J.M. Kitzen, P.T. Hoff and B.R. Lucchesi, 1988, Effects of pimobendan (UD-CG 115 BS), a new positive inotropic agent, on ventricular tachycardia and ischemic ventricular fibrillation in a conscious canine model of recent myocardial infarction, J. Cardiovasc. Pharmacol. 12, 547.
34. Lynch, J.J., A.C.G. Uprichard, J.W. Frye, E.M. Driscoll, J.M. Kitzen and B.R. Lucchesi, 1989, Effects of the positive inotropic agents milrinone and pimobendan on the development of lethal ischemic arrhythmias in conscious dogs with recent myocardial infarction, J. Cardiovasc. Pharmacol. 14, 585.
35. Momose, Y. and S. Sasayama, 1990, Effect of OPC-8490 on the membrane potentials and membrane currents of single guinea-pig myocytes, Cardiovasc. Drugs Ther. 4, 713.
36. Narimatsu, A., Y. Kitada, N. Satoh, R. Suzuki and H. Okushima, 1987, Cardiovascular pharmacology of 6-[4-(4′-pyridil)aminophenyl]-4,5-dihydro-3(2H)-pyridazinone hydrochloride, a novel and potent cardiotonic agent with vasodilator properties, Arzneim.-Forsch./Drug Res. 37, 398.
37. 2+ activation of skinned human myocardium, Eur. J. Pharmacol. 165, 305.
38. Ruegg, J.C., G. Pfitzer, D. Eubler and C. Zeugner, 1984, Effect on contractility of skinned fibers from mammalian heart and smooth muscle by a new benzimidazole derivative, 4,5-dihydro-6-[2-(4-methoxy-phenyl)-1H-benzimidazole-5-yl]-5-methyi-3(2H)- pyriclazinone, Arzneim.-Forsch./Drug Res. 34, 1736.
39. Satoh, N., Y. Abe, Y. Kitada, A. Narimatsu and A. Tobe, 1988, Effects of MCI-154, novel cardiotonic agent, on mean circulatory filling pressure in anesthetized dogs, Eur. J. Pharmacol. 47, 189.
40. Sawaki, S., Y. Furukawa, Y. Inoue, S. Takayama and S. Chiba, 1993, Positive chonotropic and inotropic responses to novel cardiotonics, NKH 477 and MCI-154 in isoprenalinelated, perfused canine heart preparations, Asia Pacific J. Pharmacol. 8, 133.
41. Shibuya, T., K. Hashimoto and S. Imai, 1983, Effective plasma concentrations of antiarrhythmic drugs against sustained halothane-adrenaline arrhythmia in dog, J. Cardiovasc. Pharmacol. 5, 538.
42. Takase, H., T. Mori, K. Sekiguchi and T. lijima, 1994, OPC-18790, a quinolinone-derivative positive inotropic agent, inhibits potassium currents in guinea-pig ventricular myocytes, Jpn. J. Pharmacol. 64 (Suppl. 1), 102.
43. Westfall, M.V., G.M. Wahler, K. Fujino and R.J. Solaro, 1992, Electrophysiological actions of the pimobendan metabolite, UD-CG 212 Cl, in guinea pig myocardium, J. Pharmacol. Exp. Ther. 260, 58.
44. Wu, Z., T. Awaji, H. Abe, S. Motomura and K. Hashimoto, 1993, Effects of OPC-18790, a new positive inotropic agent, on canine ventricular arrhythmias, Jpn. J. Pharmacol. 63, 399.